降低心血管危险，调脂策略需要转变？
Does the Strategy of Lipid Management to Reduce Cardiovascular Risk Need to be Changed?
其它心血管危险因素在处理上是一致的。
背景儿童期肥胖症与心血管危险升高相关。
BACKGROUND Obesity in childhood is associated with increased cardiovascular risk.
结论CRP与传统心血管危险因子相关联。
Conclusions CRP was related to the traditional cardiovascular risk factors.
各种心血管危险因素在该人群中有聚集现象。
There was aggregation of variable cardiovascular risk factors in this population.
预测遗传的心血管危险因素：我们能做到吗？
那么您认为锻炼对血压和心血管危险因素有什么影响？
Therefore, in your opinion, what's the influence of exercise on blood pressure and cardiovascular risk factors?
心血管危险因素以及血管病病史可增加AD发病的危险。
Cardiovascular risk factors and a history of vascular disease can increase the risk of Alzheimer's disease (AD).
肥胖引起的心血管危险因素与血管内皮功能障碍密切相关。
The cardiovascular dangerous factors which obesity leads to are closely correlated with the dysfunction of vascular endothelium.
低水平LDL-C维持时间越长，心血管危险降低越显著；
The longer the low LDL-C level is kept , the better for risk reduction.
研究者还评估调查对象的心血管危险因素，如糖尿病和吸烟。
They were also assessed for cardiovascular risk factors such as diabetes and smoking.
综合心血管危险因素管理比单一危险因素管理更具成本效益。
Total CV risk management is much more cost-effective than single-risk-factor management.
目的探讨c反应蛋白(crp)与传统心血管危险因子的相关性。
Objectives to investigate the relationship between C-reactive protein (CRP) and traditional cardiovascular risk factors.
肺动脉压可能是一个新的心血管危险因素且是一个潜在的治疗目标。
Pulmonary artery pressure may serve as a novel cardiovascular risk factor and potential therapeutic target.
目的研究动脉硬度指数（ASI）预测高血压患者心血管危险的价值。
ObjectiveThis study was designed to explore the clinical value of arterial stiffness index(ASI)predicting cardiovascular risk in hypertensive patients.
目的：探讨高血压合并其他心血管危险因素的程度及对冠状动脉血管的影响。
Objective: This study investigated the degree of other risk factors complicated by coronary artery disease (CAD) and their influence on coronary artery in hypertensive patients.
这一结论进一步证实了2型糖尿病需防治进展性早期心血管危险因子的必要性。
This further supports the need for aggressive early cardiovascular risk factor management in type 2 diabetes.
目的为了了解高血压前期与多代谢异常、代谢综合征及心血管危险因素的关系。
Objective to study the relation of prehypertensive and multiple metabolic disorders, metabolic syndrome and CVD risk factors.
结论：CRP与SLE的病情活动无相关，与SLE患者心血管危险因素相关。
Conclusion: CRP is correlated with the risk of cardiovascular disease, not SLE disease activity.
当我们看心血管危险因素时，采用这些药物，几乎每个心血管危险因素都转好。
When we look at cardiovascular risk factors, almost every single cardiovascular risk factor got better with these agents.
我们正试图在更大范围上减少心血管危险因素，处理高血压只是其中的一部分。
So we are trying to very comprehensively deal with cardiovascular risk reduction and hypertension management is only a part of that.
通过年龄，吸烟，体重，血压，支气管问题，呼吸和心血管危险对研究加以校正。
It adjusted for age, smoking, weight, blood pressure, bronchial problems, breathing, and cardiovascular risk.
这种相关性并不能通过体重和传统心血管危险因素、肾功能之间的关系充分解释。
This relationship cannot be fully explained by the association between weight and classical cardiovascular risk factors and renal function.
必须有进一步大规模研究来确定妊娠期体重增加对子女心血管危险度因素的影响范围。
Further large studies are required to confirm an effect of GWG on a range of offspring cardiovascular risk factors.
目的通过运动锻炼和饮食控制，观察肥胖或超重者的体重减轻对心血管危险因素的影响。
Objective: to observe the effects of weight reduction on cardiovascular risk factors in obese or overweight persons by exercise and energy intake controlling.
目前的心脏康复训练的方案只能轻度减少体重，而且对减少心血管危险因素也作用甚微。
Current CR exercise protocols result in little weight loss and minimal changes in cardiac risk factors.
糖尿病是“常见”心血管危险复合因素中的重要部分，其可导致动脉壁血栓形成加速和恶化。
Diabetes is an important component of the complex of 'common' cardiovascular risk factors, and is responsible for acceleration and worsening of atherothrombosis.
结论：2型糖尿病患者常有多种心血管危险因素聚集，冠心病合并2型糖尿病者多支病变常见。
Conclusion: There are many cardiovascular risk factors in patients with 2 -type diabetes. The CHD patients complicated with 2 -type diabetes often have multi-branch lesions.
结论：GLP - 1受体激动剂治疗后的体重减轻与心血管危险因素谱向更有益的方向转变有关。
CONCLUSIONS Weight reduction with GLP-1 receptor agonists was associated with a shift toward a more favorable cardiovascular risk profile.
结论：GLP - 1受体激动剂治疗后的体重减轻与心血管危险因素谱向更有益的方向转变有关。
CONCLUSIONS Weight reduction with GLP-1 receptor agonists was associated with a shift toward a more favorable cardiovascular risk profile.
应用推荐